Medical Affairs North America, Merz Aesthetics, Raleigh, North Carolina, USA.
College of Medicine, University of Central Florida, Orlando, Florida, USA.
J Cosmet Dermatol. 2024 Jun;23(6):1973-1984. doi: 10.1111/jocd.16216. Epub 2024 Feb 15.
Calcium hydroxylapatite-carboxymethylcellulose (CaHA-CMC) injectables have emerged as dual-purpose fillers with bioregenerative and direct filling capabilities.
This study investigates the rheological properties of CaHA-CMC and its CMC carrier gel at various dilutions.
The storage modulus (G'), loss modulus (G″), complex viscosity (η*), loss factor (tan δ), cohesivity, and extrusion force were evaluated for a range of CaHA-CMC aqueous dilutions with an oscillatory rheometer, drop weight testing, and force analysis, respectively.
Results revealed a significant decrease in G', η*, and increase in tan(δ) with increasing dilution, indicating a decline in the product's direct filling capabilities. Cohesivity decreased dramatically with dilution, potentially enhancing tissue biointegration and the product's biostimulatory effects. The CMC gel carrier displayed inelastic and non-resilient properties, with rheological changes differing from CaHA-CMC. Dilutional rheology was also correlated with previously published dilution-dependent biostimulatory data where hyperdiluted CaHA-CMC (>1:2) demonstrated a regenerative profile and diluted or hypodiluted mixtures retained meaningful filling properties and increased regeneration.
These findings offer a continuum for tailoring the product's rheological profile to match specific tissue requirements. Customizable rheology allows CaHA-CMC to be tuned for either filling and contouring or optimal regenerative effects. Importantly, safety implications related to vascular occlusion suggest that dilutional rheomodulation decreases the risk of vascular events. In conclusion, this study highlights the significant impact of aqueous dilution on the rheological properties of CaHA-CMC and its carrier gel. The findings support the clinical application of tailored dilutions to achieve desired outcomes, providing versatility and safety for aesthetic applications.
钙羟磷灰石-羧甲基纤维素(CaHA-CMC)注射剂已成为具有生物再生和直接填充能力的两用填充剂。
本研究旨在研究 CaHA-CMC 及其 CMC 载体凝胶在不同稀释度下的流变特性。
使用振荡流变仪、落锤试验和力分析分别评估了一系列 CaHA-CMC 水性稀释液的储能模量(G')、损耗模量(G″)、复合粘度(η*)、损耗因子(tan δ)、内聚性和挤出力。
结果表明,随着稀释度的增加,G'、η*显著降低,tan δ 增加,表明产品的直接填充能力下降。随着稀释度的增加,内聚性急剧下降,可能增强组织生物整合和产品的生物刺激作用。CMC 凝胶载体表现出非弹性和非弹性的特性,流变变化与 CaHA-CMC 不同。稀释流变学也与先前发表的稀释依赖性生物刺激数据相关,其中超稀释 CaHA-CMC(>1:2)表现出再生特征,稀释或低稀释混合物保留有意义的填充特性和增加再生。
这些发现为根据特定组织需求调整产品流变特性提供了一个连续体。可定制的流变学允许 CaHA-CMC 针对填充和轮廓塑造或最佳再生效果进行调整。重要的是,与血管闭塞相关的安全性问题表明,稀释流变调节降低了血管事件的风险。总之,本研究强调了水稀释对 CaHA-CMC 及其载体凝胶流变特性的重大影响。研究结果支持应用经稀释的制剂来达到预期的效果,为美容应用提供了多功能性和安全性。